GCH1, identified by a ferroptosis-related prognostic model, contributes to progression and drug resistance of esophageal cancer.
This study established a ferroptosis-related prognostic model for esophageal cancer and identified GCH1 as a critical regulator that contributes to esophageal cancer progression and drug resistance.